G A Hofmann

755 total citations
10 papers, 657 citations indexed

About

G A Hofmann is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, G A Hofmann has authored 10 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in G A Hofmann's work include Cancer therapeutics and mechanisms (6 papers), Synthesis and biological activity (2 papers) and DNA Repair Mechanisms (2 papers). G A Hofmann is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Synthesis and biological activity (2 papers) and DNA Repair Mechanisms (2 papers). G A Hofmann collaborates with scholars based in United States, United Kingdom and Austria. G A Hofmann's co-authors include Michael R. Mattern, F L McCabe, Richard K. Johnson, Randall K. Johnson, Richard Woessner, F H Drake, Christopher K. Mirabelli, R K Johnson, Wai-Kwong Eng and Robert Hertzberg and has published in prestigious journals such as Molecular Pharmacology, European Food Research and Technology and Regulatory Peptides.

In The Last Decade

G A Hofmann

10 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G A Hofmann United States 7 600 336 147 78 60 10 657
Janice Mayes United States 10 496 0.8× 301 0.9× 82 0.6× 77 1.0× 52 0.9× 17 549
K W Kohn United States 7 325 0.5× 234 0.7× 26 0.2× 30 0.4× 12 0.2× 9 465
Carla Soranzo Italy 11 164 0.3× 163 0.5× 27 0.2× 81 1.0× 7 0.1× 21 363
Sueo Mukumoto Japan 8 310 0.5× 120 0.4× 17 0.1× 61 0.8× 8 0.1× 9 495
Barbara Kowalska‐Loth Poland 11 276 0.5× 62 0.2× 35 0.2× 16 0.2× 13 0.2× 25 431
Masami Bungo Japan 7 264 0.4× 242 0.7× 39 0.3× 27 0.3× 11 0.2× 10 396
Sanjay Adhikari United States 13 417 0.7× 116 0.3× 10 0.1× 37 0.5× 15 0.3× 23 468
Yushu Hao China 9 233 0.4× 55 0.2× 39 0.3× 192 2.5× 11 0.2× 22 445
Elizabeth A. Dulmadge United States 11 226 0.4× 144 0.4× 12 0.1× 49 0.6× 7 0.1× 22 376
Derek P. Logsdon United States 8 455 0.8× 147 0.4× 9 0.1× 26 0.3× 10 0.2× 15 571

Countries citing papers authored by G A Hofmann

Since Specialization
Citations

This map shows the geographic impact of G A Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G A Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G A Hofmann more than expected).

Fields of papers citing papers by G A Hofmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G A Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G A Hofmann. The network helps show where G A Hofmann may publish in the future.

Co-authorship network of co-authors of G A Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of G A Hofmann. A scholar is included among the top collaborators of G A Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G A Hofmann. G A Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Mattern, Michael R., et al.. (1993). In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells.. PubMed. 5(12). 467–74. 76 indexed citations
3.
Woessner, Richard, Wai-Kwong Eng, G A Hofmann, et al.. (1992). Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content.. PubMed. 4(11-12). 481–8. 63 indexed citations
4.
Aiyar, Nambi, Michael R. Mattern, G A Hofmann, Ruth Edwards, & P Nambi. (1991). Down regulation of calcitonin gene-related peptide (CGRP)-mediated cAMP accumulation in ras transformed 3T3 fibroblasts. Regulatory Peptides. 34(2). 99–99. 1 indexed citations
5.
Mattern, Michael R., G A Hofmann, F L McCabe, & Randall K. Johnson. (1991). Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).. PubMed. 51(21). 5813–6. 135 indexed citations
6.
Woessner, Richard, Theodore D. Chung, G A Hofmann, et al.. (1990). Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.. PubMed. 50(10). 2901–8. 88 indexed citations
7.
Eng, Wai-Kwong, F L McCabe, K. B. Tan, et al.. (1990). Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.. Molecular Pharmacology. 38(4). 471–480. 106 indexed citations
8.
Morrison, Dennis R. & G A Hofmann. (1990). Cell separation and electrofusion in space. NASA Technical Reports Server (NASA). 1 indexed citations
9.
Drake, F H, G A Hofmann, Shau Ming Mong, et al.. (1989). In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone.. PubMed. 49(10). 2578–83. 147 indexed citations
10.
Hofmann, G A, et al.. (1961). �ber die photometrische Bestimmung von Diphenyl und o-Hydroxy-diphenyl in Citrusfruchtschalen. European Food Research and Technology. 114(2). 97–105. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026